About hemaxisdbs
This author has yet to write their bio.Meanwhile lets just say that we are proud hemaxisdbs contributed a whooping 30 entries.
Entries by hemaxisdbs
La FIT soutient deux entreprises dans le domaine des sciences de la vie
July 7, 2015 in News /by hemaxisdbsDBS System a obtenu un prêt Early de 300’000 francs. L’entreprise révolutionne et simplifie les prises de sang. DBS System développe et fabrique un dispositif intelligent de type ‘chip microfluidique’ (format carte de crédit) pour le micro-prélèvement de sang au bout du doigt, en fonctionnalisant le support absorbant, un filtre communément appelé Dried Blood Spot […]
DBS System in the online newspaper Mergermarket
April 23, 2015 in News /by hemaxisdbsDBS System to raise up to CHF 12M to launch lab-on-chip device for dry blood and plasma samples Privately owned DBS System is seeking investors to raise a CHF 2m Series A by 4Q15 and a CHF 10m Series B in 1Q17, Chief Executive Officer Eric Ödman said on the side-lines of the 20th MedTech […]
Interview with DBS Systems, the revolution in blood collection
April 15, 2015 in News /by hemaxisdbsDBS System is a medtech startup founded in December 2010 and located in the Swiss Health Valley. The company develops smart solutions to simplify the life of millions of people needing blood analyses worldwide. The DBS System device brings a revolution in blood collection with its ability of standardizing samplings everywhere, at any time and […]
DBS System mentioned in the press release of “La Côte” of March 19th
March 9, 2015 in News /by hemaxisdbsLink to Article Source: http://goo.gl/66W6kh
Selected Companies for the Entente Life Sciences Investment Forum
March 5, 2015 in News /by hemaxisdbsThe partners of the ENTENTE-project together with the European Commission and EuropaBio (the European association for BioIndustries) are proud to announce the companies selected to present at the ENTENTE Life Sciences Investment Forum, taking place on October 9th at the Stanhope Hotel in Brussels, during the 2014 European Biotech Week. Selected companies The 28 European […]
Démocratiser la prise de sang?
July 8, 2014 in Uncategorized /by hemaxisdbsC’est une question à laquelle une jeune start-up de l’arc alémanique, DBS System, tente de répondre… DBS System, créée en 2010, concentre ses efforts sur le développement et la commercialisation d’un dispositif médical permettant de générer un spot de sang complet et/ou de plasma ultra pur de manière entièrement passive. Au format carte de crédit, […]
Medtech. La start-up DBS System a développé une plaque microfluidique….
June 14, 2014 in News /by hemaxisdbsL’avance technologique reconnueMedtech. La start-up DBS System a développé une plaque microfluidique pour remplacer la seringue. Une levée de fonds est en cours.Fini la peur des seringues. Le processus de prise de sang connaît une évolution importante et moins traumatisante. Basée à Gland, la start-up DBS System souhaite moderniser une méthode datant des années 1970 […]
DBS System révolutionne et simplifie les prises de sang
May 9, 2014 in News /by hemaxisdbsDBS System révolutionne et simplifie les prises de sang Bientôt, il ne sera plus nécessaire de se rendre chez son médecin ou dans un centre de prélèvement pour effectuer une prise de sang, ni de subir une piqûre dans le bras, souvent effrayante pour les enfants. Il sera possible de le faire chez soi en […]
DBS System is selected by the Alpine Venture Forum committee to present its innovative micro-sampling solution.
May 6, 2014 in News /by hemaxisdbsThe event will be a unique occasion for the most promising Life Sciences, Clean Technology and Information Technology entrepreneurs from Switzerlandand its surrounding regions (including Rhône Alpes, Franche Comté, Alsace, Baden Würtemberg, Bayern, Tirol, Aosta, Piemonte, Lombardia, Trentino Alto Adige – Süd Tirol) to meet and present themselves to active international investors and corporations seeking investment […]
DISCLAIMER
HemaXis DB is a FDA Class 1 medical device. HemaXis DX is in development and for research purposes only. Use of HemaXis devices in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with local regulatory requirements.
By using this website you are agreeing to our Terms and Conditions.
CONTACT
DBS System SA
Rte des Avouillons 6
CH-1196 Gland
Switzerland
Tel: +41 (0) 78 624 70 15
Email: info@dbs-system.ch
LEGAL DOCUMENTS
Read Our Privacy Policy
Read Our General Terms and Conditions of Sale
Read Our Shipping Information